A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis.
IBM Watson has sealed a deal with yet another pharmaceutical company – this time with Lundbeck to create innovative medicines for disorders of the central nervous system.
As cognitive computing increasingly permeates all areas of life, Kyu Rhee, chief health officer at IBM Watson Health, speaks with pharmaphorum’s Andrew McConaghie
New technologies and new business models are transforming life science companies. A new book from Accenture maps out the fresh approaches being taken across healthcare.
Seismic Therapeutic has raised $121 million in second-round financing that will be used to take its two lead drugs through early-stage clinical testing.
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio